FINANCING DIALOGUE
Investing in the World’s Health Organization
WHO’s Financing Dialogue 2016
A proposal for increasing the assessed contribution
Ensuring sustainable financing for WHO
INTRODUCTION
1.
WHO is the world’s directing and coordinating authority on international health. Its mission is
to promote and protect the health of all peoples.
2.
WHO's work is financed through dues paid by Member States to the Organization (assessed
contributions) and through voluntary contributions from Member States, international organizations
and non-State actors. A small part of voluntary contributions and the assessed contributions make up
the flexible resources of the Organization.
3.
When WHO was created in 1948, the intention was for it to be funded principally from the
assessed contribution to enable the Organization to meet its primary mandate as a normative and
technical agency. Although voluntary contributions, intended for special programmes, started growing
during the late 1970s, assessed contributions were the predominant source of financing for the
programme budget until the late 1990s.
4.
Over the past decade, the total financing of the Organization has increased significantly. The
increase in total financing has been mainly driven by voluntary contributions, which are largely
specified to certain areas of the programme budget.
5.
In the past 10 years, the assessed contribution from Member States has been stable nominally.
This means that, with voluntary contributions increasing during the same period, the proportion of the
programme budget financed from assessed contributions has declined over time.
1
FINANCING DIALOGUE
Investing in the World’s Health Organization
Figure 1. Trends in WHO financing, assessed contributions and voluntary contributions 1998–2017
6.
At same time, the International Monetary Fund projects cumulative global inflation for the
period 2010-2017 at 30.4%, with the annual average being 3.8%.1
7.
The stagnant level of assessed contributions and the resulting decline in the proportion they
fund out of the total budget is a cause of concern for the sustainability of the Organization. Reversing
this trend is important for securing the future of the world’s health organization.
8.
Therefore, the Director-General is proposing to raise the assessed contribution by 10%,
which represents a total increase of US$ 93 million. This is in line with the recommendations of
the United Nations High-level Panel on the Global Response to Health Crises.2
What does WHO use assessed contributions for?
9.
The Organization currently receives a total of US$ 929 million in assessed contributions. These
finance only 20% of the programme budget.
10. Under the new financing model of the Organization, assessed contributions are mainly used for
the following:
(a) Providing the funding to sustain the governing body mechanisms, the Secretariat’s
leadership structure, at global, regional and country levels. Assessed contributions are a
main source of funding for the backbone of the Organization, namely governance and leadership
functions, including the salaries of the Director-General, the regional directors and WHO
representatives in countries, and enable WHO to maintain its presence in more than 150
countries, which is a significant asset for bringing WHO’s support closer to where it matters.
2
http://www.un.org/News/dh/infocus/HLP/2016-02-05_Final_Report_Global_Response_to_Health_Crises.pdf
(accessed 19 October 2016).
2
FINANCING DIALOGUE
Investing in the World’s Health Organization
(b) Maintaining an effective and efficient management and administration. Assessed
contributions pay a portion of the cost of keeping the Organization operating by funding in part
the management and administrative functions, including finance, human resource management
and security. Assessed contributions are used to fund the functions that promote and improve
accountability for resources, transparency and ensure that sufficient control functions are in
place.
(c) Promoting the alignment of resources to the Organization’s priorities. The strategic
allocation of flexible resources allows the Director-General to compensate for insufficient
alignment of specified voluntary contributions with the priorities decided collectively by the
Member States. Assessed contributions have become the life-blood of several core programme
areas and a catalyst in others. For example, the new Health Emergencies Programme has
received so far funding of about US$ 60 million from assessed contributions in 2016 along with
additional flexible resources.
11. How much assessed contributions are used for those areas and functions is illustrated in Figure
2. Assessed contributions are important as the main funding source for these critical areas and
functions. More than half the total assessed contribution is dedicated to technical programmes’
priorities to meet their core needs in carrying out their normative, policy and coordination functions.
Figure 2. Expenditures from assessed contribution, 2014-2015 (in US$ million)
Why does WHO need an increase in assessed contributions?
12.
There are at least four reasons why an increase in assessed contributions is vital:
(a) Ensuring security for critical programmes/functions. With only about 20% financing of
the programme budget coming from assessed contributions, WHO is highly vulnerable to
fluctuations in voluntary contributions. One of the hard lessons from the Ebola crisis was that
WHO needs to retain a sufficient core capacity and readiness to respond even before an event
becomes a health emergency with the speed and scale that is necessary. This ability had been
reduced severely when the voluntary contributions dropped remarkably in the biennium 20102011. The Ebola crisis was a wake-up call that exposed the need for a transformation of WHO,
3
FINANCING DIALOGUE
Investing in the World’s Health Organization
including the way its work is financed. Stable and flexible financing is essential to secure its
core capacity to be able to withstand any unforeseen crises.
(b) Strengthening the leverage value of assessed contributions. Since 2014, assessed
contributions are not appropriated in advance, but Member States approve the budget in its
entirety. This fundamental change has allowed a more strategic use of assessed contributions.
The Secretariat has been better able to correct the misalignment between financing and the
priorities of Member States; it is achieving this by distributing part of the assessed contributions
to priorities that receive less funding through voluntary contributions. With the operational
capacity being secured through assessed contributions, WHO’s programmes are in a better
position to leverage other resources for achieving their intended results. Annex 2 shows the
programme areas that rely most on assessed contributions in the previous biennium.
(c) Safeguarding the gains achieved when programmatic priorities change. Public health
investments in certain programmes have far-reaching implications for other programmes and
systems. However, some donor-based investments are time-limited, particularly when the
specific results are achieved or donors’ priorities or circumstances changes. Perhaps the most
pressing example is the inevitable reduction in investments for the polio eradication programme
in the next few years. The strong capacity and networks of disease surveillance, health planning,
immunization and community mobilization built through the polio eradication programme in
countries have provided the anchor for the operations of many other programmes. Assessed
contributions will be crucial to safeguard these capacities, skills and systems in order to sustain
the gains made in all programmes.
(d) Making strategic, multi-year investments. The uniquely stable nature of assessed
contributions will enable the Organization to make commitments on important agenda,
resolutions and strategies that will require significant initial and multi-year investments. This is
important as the world moves towards the implementation of the 2030 Agenda for Sustainable
Development, in which WHO plays a pivotal role. WHO will need assessed contributions to
build capacity in certain areas that will leverage longer-term support needed in research and
development, global advocacy, individual country support for implementing the Sustainable
Development Goals, especially Goal 3 (Ensure healthy lives and promote well-being for all at
all ages).
How will the increase in assessed contributions be used?
13. If agreed, the increase in assessed contributions of US$ 93 million for the biennium 2018-2019
will achieve the following results.
14. The additional assessed contributions will enable the Organization to implement the agreed plan
for its transformation into an agency that is more operational and ready at all times to mount a rapid
response to health emergencies.
15. The additional assessed contributions will immediately have an impact on the financing levels
of the chronically underfunded areas, such as noncommunicable diseases, health and the environment,
and nutrition. These areas struggle to generate good momentum for implementation at the beginning
of the biennium owing to the lack of predictable and stable funding.
4
FINANCING DIALOGUE
Investing in the World’s Health Organization
16. It will build staff capacity in the underfunded areas that have recently been declared by Member
States as global priorities, such as antimicrobial resistance, dementia, and ageing and health. Initial
funding from assessed contributions will be useful to establish WHO’s capacity, which could then be
used to lever greater support from national and international sources.
17. It will help to buy global public goods that require sustained investments over time. For
example, WHO will be able to engage in creating public health innovations that are otherwise not
picked up by commercial interests, strengthen its role as guardian of the implementation of the
International Health Regulations (2005), and build alert systems that contribute to global health
security.
18. Finally, increased assessed contributions will allow WHO to make investments in strengthening
its country presence, especially in highly vulnerable countries. For example, WHO offices in countries
such as Nigeria will need additional assessed contributions to sustain the unprecedented gains in polio
eradication and help to retain the country capacity built through funding for polio eradication to
benefit other programmes, such as health emergencies, health systems strengthening and disease
surveillance. Additional assessed contributions will help to retain sufficient human resource capacity
that will help to leverage resources from domestic sources and partners.
How will WHO use assessed contributions responsibly?
19. Through a combination of measures implemented in the WHO reform, the Organization is in a
better position to optimize the value of the assessed contribution and ensure the proper use of
resources entrusted to WHO. WHO has made significant progress in the following areas.
20. Stewardship for better results. WHO continues to strengthen its stewardship for better results.
The programmatic reforms have led to improvements in accountability for results through better
defining the results chain and improved priority-setting. The Organization continues to improve its
priority-setting through a robust and consultative process for developing the programme budget, with
engagement of Member States, partners and all levels of the Organization. Through this process, all
offices narrow down the focus of their work to a limited set of priorities. For the biennium 2018-2019,
more than 75% of country offices have allocated 80% of their budgets to up to 10 priority
programmes. WHO will make sure that assessed contributions are used for delivering results,
especially at country level. It will report results in a transparent and timely manner.
21. Improved accountability, transparency and control measures. Internal control and
accountability frameworks are now being implemented across the Organization, encompassing all
processes that have financial and human resources consequences. There is an accountability compact
between the Director-General and Assistant Directors-General, and Letters of Representation for
Regional Directors have been published. Compliance functions have been established in all major
offices and an Organization-wide risk management system is in place. The Organization has made
significant gains in ensuring transparency through innovations such as the programme budget web
portal, the joint reporting of the financial situation and programmatic achievements, and independent
corporate evaluations. WHO will be joining the International Aid Transparency Initiative in November
this year. The Secretariat is ensuring that Member States are able to track how resources are
spent and what results are being achieved in a much more transparent way.
5
FINANCING DIALOGUE
Investing in the World’s Health Organization
22. Delivering value-for-money. Facing constraints on its resources, WHO has made substantial
efforts to find most efficient ways for delivering its work. Evidence of this is the reduction in
expenditure on staff (the biggest expenditure item in WHO) as a proportion of the overall expenditure
by about 10% over the past six years. Several cost-saving measures with longer-term impact have been
implemented, such as the relocation of corporate-wide services on finance, human resources and
information technology to Malaysia and Hungary, at lower staff costs than Geneva. Travel ceilings
have been established across all offices to cap travel costs and promote the use of technology in order
to deliver the work more efficiently. Measures to improve economies of scale and to avoid
duplication, including harmonized, globally shared information technology products and better
coordinated procurement planning, have been strengthened. This demonstrates that the Organization is
maximizing the use of the assessed contributions available for delivering results and will continue to
do so.
23. The Secretariat is currently developing a comprehensive and detailed value-for-money
plan to be submitted to the Executive Board in 2018. This will include further plans to reduce costs
associated with meetings and travel, among other measures that yield high efficiencies and lower
administrative costs across the enabling functions and technical programmes.
How much more will individual Member States pay?
24. The 10% increase proposed will amount to an increase of US$ 93 million; the contributions
will be apportioned to Member States on the basis of the scale of assessments adopted by the
Health Assembly in May 2016. 1
25. Even with the proposed 10% increase in assessed contributions, about 40 countries will see a
decrease in their contributions in future years compared to their 2016 assessment when the new scale
of assessment is applied, starting in 2017.
26. Figure 3 illustrates the impact of the increase in assessed contributions to the 20 countries with
largest expected increase in their 2018 assessed contributions as compared to 2016.
1
Resolution WHA69.14, available at: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_R14-en.pdf (accessed
19 October 2016).
6
FINANCING DIALOGUE
Investing in the World’s Health Organization
Figure 3. Countries with largest expected increase in their assessed contributions for year 2018
(in US$ million)
7
FINANCING DIALOGUE
Investing in the World’s Health Organization
ANNEX 1
Assessed contributions by Member State and Associate Member showing
the 10% increase in 2018 and 2019
(All amounts are in US$)
Top contributors
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia (Plurinational State
of)
Bosnia and Herzegovina
Botswana
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
2016
23 230
46 450
636 370
37 160
46 450
9 290
2 006 640
32 520
9 634 200
3 707 180
185 800
78 970
181 160
46 450
37 160
260 120
4 636 180
4 650
13 940
4 650
41 810
2017
27 870
37 160
747 850
27 870
46 450
9 290
4 143 340
27 870
10 855 830
3 344 871
278 700
65 030
204 380
46 450
32 520
260 120
4 111 291
4 650
13 940
4 650
55 740
2018
30 657
40 876
822 635
30 657
51 095
10 219
4 557 674
30 657
11 941 412
3 679 358
306 570
71 533
224 818
51 095
35 772
286 132
4 522 420
5 115
15 334
5 115
61 314
Assessed
contributions
difference
between
2018 and 2016
7 427
(5 574)
186 265
(6 503)
4 645
929
2 551 034
(1 863)
2 307 212
(27 822)
120 770
(7 437)
43 658
4 645
(1 388)
26 012
(113 760)
465
1 394
465
19 504
78 970
78 970
13 629 360
120 770
218 320
13 940
4 650
4 650
18 580
55 740
13 861 604
60 390
65 030
17 758 770
134 700
209 030
18 580
4 650
4 650
18 580
46 450
13 568 505
66 429
71 533
19 534 647
148 170
229 933
20 438
5 115
5 115
20 438
51 095
14 925 355
(12 541)
(7 437)
5 905 287
27 400
11 613
6 498
465
465
1 858
(4 645)
1 063 751
8
2019
30 657
40 876
822 635
30 657
51 095
10 219
4 557 674
30 657
11 941 412
3 679 358
306 570
71 533
224 818
51 095
35 772
286 132
4 522 420
5 115
15 334
5 115
61 314
66 429
71 533
19 534 647
148 170
229 933
20 438
5 115
5 115
20 438
51 095
14 925 355
FINANCING DIALOGUE
Investing in the World’s Health Organization
Top contributors
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Cyprus
Czechia
Democratic
People’s
Republic of Korea
Democratic Republic of the
Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Assessed
contributions
difference
between
2018 and 2016
465
16 263
487 255
16 559 045
442 199
465
7 427
465
63 642
(5 109)
(79 424)
11 602
1 394
(35 302)
(2 317)
2016
4 650
9 290
1 551 430
23 914 320
1 203 060
4 650
23 230
4 650
176 510
51 100
585 270
320 510
218 320
1 792 970
27 870
2017
4 650
23 230
1 853 350
36 793 969
1 495 690
4 650
27 870
4 650
218 320
41 810
459 860
301 920
199 740
1 597 880
23 230
2018
5 115
25 553
2 038 685
40 473 365
1 645 259
5 115
30 657
5 115
240 152
45 991
505 846
332 112
219 714
1 757 668
25 553
13 940
37 160
40 876
26 936
40 876
3 135 380
4 650
4 650
209 030
204 380
622 430
74 320
46 450
4 650
185 800
46 450
13 940
2 410 760
28 163 070
92 900
4 650
32 520
33 172 630
65 030
2 963 510
4 650
125 420
4 650
2 712 680
4 650
4 650
213 670
311 210
706 040
65 030
46 450
4 650
176 510
46 450
13 940
2 118 120
24 752 260
78 970
4 650
37 160
29 677 840
74 320
2 187 800
4 650
130 060
9 290
2 983 948
5 115
5 115
235 037
342 331
776 644
71 533
51 095
5 115
194 161
51 095
15 334
2 329 932
27 227 486
86 867
5 115
40 876
32 645 624
81 752
2 406 580
5 115
143 066
10 219
(151 432)
465
465
26 007
137 951
154 214
(2 787)
4 645
465
8 361
4 645
1 394
(80 828)
(935 584)
(6 033)
465
8 356
(527 006)
16 722
(556 930)
465
17 646
5 569
2 983 948
5 115
5 115
235 037
342 331
776 644
71 533
51 095
5 115
194 161
51 095
15 334
2 329 932
27 227 486
86 867
5 115
40 876
32 645 624
81 752
2 406 580
5 115
143 066
10 219
9
2019
5 115
25 553
2 038 685
40 473 365
1 645 259
5 115
30 657
5 115
240 152
45 991
505 846
332 112
219 714
1 757 668
25 553
FINANCING DIALOGUE
Investing in the World’s Health Organization
Top contributors
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran (Islamic Republic of)
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Lao People’s Democratic
Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
(Federated
States of)
2016
4 650
4 650
13 940
37 160
1 235 570
125 420
3 093 570
1 607 170
1 653 620
315 860
1 941 610
1 839 420
20 662 360
51 100
50 322 850
102 190
562 050
60 390
4 650
1 268 090
9 290
9 290
2017
4 650
9 290
13 940
37 160
747 850
106 830
3 423 370
2 341 080
2 187 800
599 210
1 556 080
1 997 350
17 410 390
41 810
44 964 440
92 900
887 200
83 610
4 650
1 323 820
9 290
13 930
2018
5 115
10 219
15 334
40 876
822 635
117 513
3 765 707
2 575 188
2 406 580
659 131
1 711 688
2 197 085
19 151 429
45 991
49 460 884
102 190
975 920
91 971
5 115
1 456 202
10 219
15 323
218 320
195 090
4 650
4 650
659 590
339 090
376 250
13 940
9 290
1 305 250
4 650
18 580
74 320
4 650
9 290
60 390
8 556 560
4 650
232 250
213 670
4 650
4 650
580 630
334 440
297 280
13 940
9 290
1 495 690
9 290
13 930
74 320
4 650
9 290
55 740
6 666 040
4 650
255 475
235 037
5 115
5 115
638 693
367 884
327 008
15 334
10 219
1 645 259
10 219
15 323
81 752
5 115
10 219
61 314
7 332 644
5 115
10
Assessed
contributions
difference
between
2018 and 2016
465
5 569
1 394
3 716
(412 935)
(7 907)
672 137
968 018
752 960
343 271
(229 922)
357 665
(1 510 931)
(5 109)
(861 966)
–
413 870
31 581
465
188 112
929
6 033
37 155
39 947
465
465
(20 897)
28 794
(49 242)
1 394
929
340 009
5 569
(3 257)
7 432
465
929
924
(1 223 916)
465
2019
5 115
10 219
15 334
40 876
822 635
117 513
3 765 707
2 575 188
2 406 580
659 131
1 711 688
2 197 085
19 151 429
45 991
49 460 884
102 190
975 920
91 971
5 115
1 456 202
10 219
15 323
255 475
235 037
5 115
5 115
638 693
367 884
327 008
15 334
10 219
1 645 259
10 219
15 323
81 752
5 115
10 219
61 314
7 332 644
5 115
FINANCING DIALOGUE
Investing in the World’s Health Organization
Top contributors
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Republic of Korea
Republic of Moldova
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the
Grenadines
Samoa
San Marino
2016
55 740
13 940
23 230
287 990
13 940
46 450
46 450
4 650
27 870
7 683 300
1 175 190
13 940
9 290
418 050
4 650
3 953 360
473 790
394 830
4 650
120 770
18 580
46 450
543 470
715 330
4 278 510
2 185 714
4 650
970 810
9 262 600
13 940
1 049 770
11 325 440
9 290
4 650
4 650
2017
46 450
23 230
18 580
250 830
18 580
46 450
46 450
4 650
27 870
6 884 360
1 244 860
18 580
9 290
970 810
4 650
3 944 071
524 890
431 985
4 650
157 930
18 580
65 030
631 720
766 430
3 906 911
1 804 820
4 650
1 249 510
9 471 620
18 580
854 680
14 344 690
9 290
4 650
4 650
2018
51 095
25 553
20 438
275 913
20 438
51 095
51 095
5 115
30 657
7 572 796
1 369 346
20 438
10 219
1 067 891
5 115
4 338 478
577 379
475 184
5 115
173 723
20 438
71 533
694 892
843 073
4 297 602
1 985 302
5 115
1 374 461
10 418 782
20 438
940 148
15 779 159
10 219
5 115
5 115
4 650
4 650
13 940
4 650
4 650
13 940
5 115
5 115
15 334
11
Assessed
contributions
difference
between
2018 and 2016
(4 645)
11 613
(2 792)
(12 077)
6 498
4 645
4 645
465
2 787
(110 504)
194 156
6 498
929
649 841
465
385 118
103 589
80 353
465
52 953
1 858
25 083
151 422
127 743
19 092
(200 412)
465
403 651
1 156 182
6 498
(109 622)
4 453 719
929
465
465
465
465
1 394
2019
51 095
25 553
20 438
275 913
20 438
51 095
51 095
5 115
30 657
7 572 796
1 369 346
20 438
10 219
1 067 891
5 115
4 338 478
577 379
475 184
5 115
173 723
20 438
71 533
694 892
843 073
4 297 602
1 985 302
5 115
1 374 461
10 418 782
20 438
940 148
15 779 159
10 219
5 115
5 115
5 115
5 115
15 334
FINANCING DIALOGUE
Investing in the World’s Health Organization
Top contributors
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Thailand
The former Yugoslav
Republic of Macedonia
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
2016
4 650
4 013 750
27 870
185 800
4 650
4 650
1 783 680
794 300
464 500
4 650
4 650
1 727 940
18 580
13 810 520
116 130
46 450
18 580
13 940
4 459 670
4 863 780
167 220
13 940
1 110 160
2017
4 650
5 323 641
23 230
148 640
4 650
4 650
2 076 320
743 200
390 180
4 650
4 650
1 690 780
13 930
11 348 200
143 990
46 450
27 870
9 290
4 441 091
5 295 770
111 480
18 580
1 351 690
2018
5 115
5 856 005
25 553
163 504
5 115
5 115
2 283 952
817 520
429 198
5 115
5 115
1 859 858
15 323
12 483 019
158 389
51 095
30 657
10 219
4 885 200
5 825 347
122 628
20 438
1 486 859
Assessed
contributions
difference
between
2018 and 2016
465
1 842 255
(2 317)
(22 296)
465
465
500 272
23 220
(35 302)
465
465
131 918
(3 257)
(1 327 501)
42 259
4 645
12 077
(3 721)
425 530
961 567
(44 592)
6 498
376 699
37 160
9 290
4 650
4 650
4 650
204 380
167 220
6 169 030
88 260
4 650
27 870
459 860
2 763 780
32 520
13 930
4 650
4 650
4 650
157 930
130 060
4 729 080
120 770
4 650
41 810
478 440
2 805 580
35 772
15 323
5 115
5 115
5 115
173 723
143 066
5 201 988
132 847
5 115
45 991
526 284
3 086 138
(1 388)
6 033
465
465
465
(30 657)
(24 154)
(967 042)
44 587
465
18 121
66 424
322 358
12
2019
5 115
5 856 005
25 553
163 504
5 115
5 115
2 283 952
817 520
429 198
5 115
5 115
1 859 858
15 323
12 483 019
158 389
51 095
30 657
10 219
4 885 200
5 825 347
122 628
20 438
1 486 859
35 772
15 323
5 115
5 115
5 115
173 723
143 066
5 201 988
132 847
5 115
45 991
526 284
3 086 138
FINANCING DIALOGUE
Investing in the World’s Health Organization
Top contributors
United Kingdom of Great
Britain and Northern
Ireland
United Republic of
Tanzania
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela (Bolivarian
Republic of)
Viet Nam
Yemen
Zambia
Zimbabwe
Total
Assessed
contributions
difference
between
2018 and 2016
2016
2017
2018
24 058 300
20 731 580
22 804 738
(1 253 562)
22 804 738
41 810
113 513 160
241 540
69 680
4 650
46 450
113 513 160
366 950
106 830
4 650
51 095
124 864 476
403 645
117 513
5 115
9 285
11 351 316
162 105
47 833
465
51 095
124 864 476
403 645
117 513
5 115
2 912 420
195 090
46 450
27 870
9 290
477 988 678
2 652 300
269 410
46 450
32 520
18 580
477 988 680
2 917 530
296 351
51 095
35 772
20 438
525 787 548
5 110
101 261
4 645
7 902
11 148
47 798 870
2 917 530
296 351
51 095
35 772
20 438
525 787 548
13
2019
FINANCING DIALOGUE
Investing in the World’s Health Organization
ANNEX 2
Programme areas supported through assessed contributions in 2014-2015
Programme areas
Health Assemblyapproved
Programme budget
Assessed
contribution
funding
Assessed
contribution
reliance in %
1.5 Vaccine-preventable diseases
346.8
24.2
7%
1.2 Tuberculosis
130.9
14.7
11%
1.3 Malaria
4.3 Access to medicines and health
technologies and strengthening regulatory
capacity
91.6
16.8
18%
145.5
29.0
20%
1.1 HIV/AIDS
131.5
27.1
21%
88.0
18.8
21%
102.0
22.0
22%
32.5
7.6
23%
5.3 Emergency risk and crisis management
3.5 Health and the environment
5.4 Food safety
3.1 Reproductive, maternal, newborn and
child health
189.9
44.7
24%
5.1 Alert and response capacities
98.0
26.4
27%
2.3 Violence and injuries
31.1
8.4
27%
2.4 Disability and rehabilitation
15.5
4.2
27%
1.4 Neglected tropical diseases
4.1 National health policies, strategies and
plans
91.3
25.0
27%
125.7
35.3
28%
2.5 Nutrition
40.0
11.4
28%
5.2 Epidemic- and pandemic-prone disesases
68.5
20.6
30%
2.2 Mental health and substance abuse
39.2
12.7
32%
4.2 Integrated people-centred health services
151.5
51.5
34%
2.1 Noncommunicable diseases
192.1
65.4
34%
6.4 Management and administration
334.3
127.5
38%
3.4 Social determinants of health
3.3 Gender, equity and human rights
mainstreaming
30.3
11.9
39%
13.9
5.5
40%
9.5
4.1
43%
4.4 Health systems Information and evidence
6.2 Transparency, accountability and risk
management
108.4
46.3
43%
50.4
23.0
46%
6.1 Leadership and governance
6.3 Strategic planning, resource coordination
andreporting
227.7
165.4
73%
34.5
26.8
78%
37.1
31.9
86%
2957.7
908.1
31%
3.2 Ageing and health
6.5 Strategic communications
Grand total
=
=
14
=